Discovering a potent small molecule inhibitor for gankyrin using de novo drug design approach
{{output}}
Gankyrin is an oncoprotein composed of six ankyrin repeats, over-expressed in the Hepatocellular Carcinoma (HCC), and directly involved in the cell cycle regulation. Therefore, it is a potential drug target to restrict the growth of cancer cell and activation ... ...